Karl Langer

1.0k total citations
35 papers, 583 citations indexed

About

Karl Langer is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Karl Langer has authored 35 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Nephrology and 6 papers in Surgery. Recurrent topics in Karl Langer's work include Barrier Structure and Function Studies (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Karl Langer is often cited by papers focused on Barrier Structure and Function Studies (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Karl Langer collaborates with scholars based in Germany, Canada and Italy. Karl Langer's co-authors include W. Thoenes, Gerd Utermann, G. H. Thoenes, R. R. Bartlett, M. Hropot, R Schleyerbach, W. Schoenborn, É Straub, Gabriele Wiemer and Wolfgang Linz and has published in prestigious journals such as Kidney International, Clinical Orthopaedics and Related Research and Cell and Tissue Research.

In The Last Decade

Karl Langer

34 papers receiving 541 citations

Peers

Karl Langer

SURGE

PHYSI

NEPHR

CCM

A. L. Baldwin United States

J. F. Lenz United States

M. F. Allard Canada

Masahiro Koide Japan

More Rh

Medhat O. Hassan United States

Zhengyu Pang United States

Mark Ingram United States

Claus B. Andersen Denmark

Seong Jae Choi South Korea

A. L. Baldwin United States

Karl Langer

114 ×0.6

136 ×1.2

SURGE

86 ×1.0

PHYSI

21 ×0.3

NEPHR

101 ×1.7

CCM

Citations per year, relative to Karl Langer Karl Langer (= 1×) peers A. L. Baldwin

Countries citing papers authored by Karl Langer

Since Specialization

Citations

This map shows the geographic impact of Karl Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Langer more than expected).

Fields of papers citing papers by Karl Langer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Langer. The network helps show where Karl Langer may publish in the future.

Co-authorship network of co-authors of Karl Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Langer. A scholar is included among the top collaborators of Karl Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Langer. Karl Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamieson, Douglas H., et al.. (2016). The treatment of abdominoscrotal hydrocele: Is there a role for nonoperative management?. Journal of Pediatric Surgery. 51(5). 815–818. 10 indexed citations

Sawodny, Oliver, et al.. (2009). Vibration damping for a hydraulic driven luffing cylinder at a boom crane using feedforward control. 6. 1276–1281. 7 indexed citations

Hropot, M., et al.. (2003). Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 367(3). 312–317. 10 indexed citations

Hropot, M., et al.. (2001). S3226, a novel NHE3 inhibitor, attenuates ischemia-induced acute renal failure in rats. Kidney International. 60(6). 2283–2289. 30 indexed citations

Linz, Wolfgang, et al.. (1998). Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats. Kidney International. 54(6). 2037–2044. 18 indexed citations

Fuchs, Holger, et al.. (1998). Subchronic Intravenous Toxicity Studies with γ-Cyclodextrin in Rats. Regulatory Toxicology and Pharmacology. 27(2). 189–198. 28 indexed citations

Mrowka, Christian, G. H. Thoenes, Karl Langer, & R. R. Bartlett. (1994). Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide. Annals of Hematology. 68(4). 195–199. 12 indexed citations

Hropot, M., et al.. (1994). Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(6). 646–52. 32 indexed citations

Küchle, Claudius, G. H. Thoenes, Karl Langer, et al.. (1991). Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.. PubMed. 23(1 Pt 2). 1083–6. 37 indexed citations

10.

Schauder, P., Jann Arends, Gertrud Schäfer, Karl Langer, & Dennis M. Bier. (1989). Einbau von15N-Glyzin in VLDL und LDL: In-vivo-Synthese von Apolipoprotein B beim Menschen postabsorptiv und im Fastenzustand. Journal of Molecular Medicine. 67(5). 280–285. 13 indexed citations

11.

Kaye, Michael, et al.. (1989). Calcium-free dialyzate: development and applications.. PubMed. 31(3). 132–8. 4 indexed citations

12.

Thoenes, G. H., Thomas Sitter, Karl Langer, R. R. Bartlett, & R Schleyerbach. (1989). Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats. International Journal of Immunopharmacology. 11(8). 921–929. 32 indexed citations

13.

Thoenes, G. H., et al.. (1987). Cyclosporin A inhibits autoimmune experimental tubulointerstitial nephritis. Immunology Letters. 15(4). 301–306. 12 indexed citations

14.

Utermann, Gerd, et al.. (1975). Lipoproteins in lecithin-cholesterol-acyltransferase (LCAT)*-deficiency. Human Genetics. 27(3). 185–197. 22 indexed citations

15.

Langer, Karl, N Paul, & W. Thoenes. (1975). Demonstration of percellular channels in glomerular podocytes in aminonucleoside nephrosis. Virchows Archiv B Cell Pathology. 17(1). 91–96.

16.

Langer, Karl. (1973). Cleavage of the Cutis. Clinical Orthopaedics and Related Research. 91. 3–12. 1 indexed citations

17.

Utermann, Gerd, et al.. (1972). Lipoproteins in LCAT-deficiency. Human Genetics. 16(4). 295–306. 47 indexed citations

18.

Langer, Karl. (1971). Zum Inhalt erweiterter Labyrinthspalten im proximalen Nierentubulus. Virchows Archiv B Cell Pathology. 8(1). 357–360. 2 indexed citations

19.

Thoenes, W., Karl Langer, U. Pfeifer, & W. Romen. (1970). Eiweißresorptionstropfen und Lysosomen im proximalen Tubuluskonvolut der Rattenniere. Virchows Archiv B Cell Pathology. 5(1). 124–143. 24 indexed citations

20.

Langer, Karl, W. Thoenes, & Michael Wiederholt. (1968). Licht-und elektronenmikroskopische Untersuchungen am proximalen Tubuluskonvolut der Rattenniere nach intraluminaler �linjektion. Pflügers Archiv - European Journal of Physiology. 302(2). 149–165. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact